Literature DB >> 17137827

Neogenin: one receptor, many functions.

Nicole H Wilson1, Brian Key.   

Abstract

Neogenin is a multifunctional transmembrane receptor belonging to the immunoglobulin superfamily. It displays identical secondary structure to deleted in colorectal cancer (DCC), a netrin receptor that is involved in axon guidance and cell survival. Like DCC, neogenin is able to transduce signals elicited by netrin. These neogenin-netrin interactions have been implicated in tissue morphogenesis, angiogenesis, myoblast differentiation and most recently in axon guidance. Neogenin is also a receptor for repulsive guidance molecule, a glycosylphosphatidylinositol-linked protein involved in neuronal differentiation, apoptosis and repulsive axon guidance. Numerous studies have been started to elucidate the in vivo functions of neogenin, and its role in multiple aspects of development and homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17137827     DOI: 10.1016/j.biocel.2006.10.023

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  53 in total

1.  Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation.

Authors:  Zheng Zhou; Jianxin Xie; Daehoon Lee; Yu Liu; Jiung Jung; Lijuan Zhou; Shan Xiong; Lin Mei; Wen-Cheng Xiong
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

2.  The neogenin/DCC homolog UNC-40 promotes BMP signaling via the RGM protein DRAG-1 in C. elegans.

Authors:  Chenxi Tian; Herong Shi; Shan Xiong; Fenghua Hu; Wen-Cheng Xiong; Jun Liu
Journal:  Development       Date:  2013-09-04       Impact factor: 6.868

3.  Novel roles of the chemorepellent axon guidance molecule RGMa in cell migration and adhesion.

Authors:  Grace J Lah; Brian Key
Journal:  Mol Cell Biol       Date:  2012-01-03       Impact factor: 4.272

4.  Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities.

Authors:  Sophie Cardin; Mélanie Bilodeau; Mathieu Roussy; Léo Aubert; Thomas Milan; Loubna Jouan; Alexandre Rouette; Louise Laramée; Patrick Gendron; Jean Duchaine; Hélène Decaluwe; Jean-François Spinella; Stéphanie Mourad; Françoise Couture; Daniel Sinnett; Élie Haddad; Josette-Renée Landry; Jing Ma; R Keith Humphries; Philippe P Roux; Josée Hébert; Tanja A Gruber; Brian T Wilhelm; Sonia Cellot
Journal:  Blood Adv       Date:  2019-11-12

5.  Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.

Authors:  Joanna A Korecka; Elizabeth B Moloney; Ruben Eggers; Barbara Hobo; Sanny Scheffer; Nienke Ras-Verloop; R Jeroen Pasterkamp; Dick F Swaab; August B Smit; Ronald E van Kesteren; Koen Bossers; Joost Verhaagen
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

6.  Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis.

Authors:  An-Sheng Zhang
Journal:  Adv Nutr       Date:  2010-11-16       Impact factor: 8.701

Review 7.  Repulsive guidance molecules (RGMs) and neogenin in bone morphogenetic protein (BMP) signaling.

Authors:  Chenxi Tian; Jun Liu
Journal:  Mol Reprod Dev       Date:  2013-07-19       Impact factor: 2.609

8.  Overexpression of repulsive guidance molecule (RGM) a induces cell death through Neogenin in early vertebrate development.

Authors:  Grace J Shin; Nicole H Wilson
Journal:  J Mol Histol       Date:  2007-09-07       Impact factor: 2.611

9.  In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.

Authors:  Rodrigo Barderas; Marta Mendes; Sofia Torres; Rubén A Bartolomé; María López-Lucendo; Roi Villar-Vázquez; Alberto Peláez-García; Eduardo Fuente; Félix Bonilla; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

10.  Neogenin-mediated hemojuvelin shedding occurs after hemojuvelin traffics to the plasma membrane.

Authors:  An-Sheng Zhang; Fan Yang; Kathrin Meyer; Catalina Hernandez; Tara Chapman-Arvedson; Pamela J Bjorkman; Caroline A Enns
Journal:  J Biol Chem       Date:  2008-04-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.